21.07

0.99% -0.20

Catalyst Pharmaceuticals Inc (CPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CPRX? Forum Prognose

Schlusskurs vom Vortag:

$21.27

Offen:

$21.27

24-Stunden-Volumen:

1.02M

Relative Volume:

0.71

Marktkapitalisierung:

$2.58B

Einnahmen:

$460.48M

Nettoeinkommen (Verlust:

$142.80M

KGV:

17.86

EPS:

1.18

Netto-Cashflow:

$221.79M

1W Leistung:

-1.55%

1M Leistung:

+1.05%

6M Leistung:

-15.22%

1J Leistung:

-3.80%

1-Tages-Spanne:

$20.95

$21.74

1-Wochen-Bereich:

$20.72

$21.74

52-Wochen-Spanne:

$19.05

$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Firmenname

Catalyst Pharmaceuticals Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (635)

Telefon

(305) 529-2522

Adresse

355 ALHAMBRA CIRCLE, CORAL GABLES

Mitarbeiter

167

Twitter

@CatalystForRare

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

CPRX's Discussions on Twitter

Vergleichen Sie CPRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CPRX Catalyst Pharmaceuticals Inc	21.06	2.60B	460.48M	142.80M	221.79M	1.18
VRTX Vertex Pharmaceuticals Inc	423.48	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	639.93	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	430.94	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	823.90	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	185.96	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-04	Eingeleitet	Robert W. Baird	Outperform
2024-11-18	Eingeleitet	Stephens	Overweight
2024-03-14	Eingeleitet	Citigroup	Buy
2024-03-07	Eingeleitet	BofA Securities	Buy
2023-12-21	Eingeleitet	Oppenheimer	Outperform
2022-08-24	Herabstufung	ROTH Capital	Buy → Neutral
2018-09-21	Eingeleitet	Cantor Fitzgerald	Overweight
2018-09-07	Fortgesetzt	Piper Jaffray	Overweight
2016-10-05	Hochstufung	Piper Jaffray	Neutral → Overweight
2016-04-26	Herabstufung	Piper Jaffray	Overweight → Neutral
2014-09-30	Bestätigt	ROTH Capital	Buy
2014-09-16	Bestätigt	ROTH Capital	Buy
2014-09-15	Bestätigt	H.C. Wainwright	Buy
2013-10-21	Bestätigt	Aegis Capital	Buy
2013-09-24	Eingeleitet	Maxim Group	Buy
2013-09-06	Bestätigt	Aegis Capital	Buy
2013-04-18	Eingeleitet	Aegis Capital	Buy
2012-08-27	Hochstufung	Rodman & Renshaw	Mkt Perform → Mkt Outperform
2009-10-01	Hochstufung	Merriman	Sell → Neutral
2009-05-29	Herabstufung	Hapoalim	Neutral → Underperform
2009-05-29	Herabstufung	Merriman Curhan Ford	Buy → Sell
2008-12-15	Eingeleitet	Merriman Curhan Ford	Buy
2007-11-28	Eingeleitet	Rodman & Renshaw	Mkt Outperform
2007-01-31	Eingeleitet	Stifel Nicolaus	Buy
2007-01-05	Eingeleitet	First Albany	Buy

Alle ansehen

Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten

08:21 AM

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times

08:21 AM

08:03 AM

Catalyst Pharma (Nasdaq: CPRX) at Jefferies Healthcare Conference; webcast 2:00 pm GMT - Stock Titan

08:03 AM

07:30 AM

Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com

07:30 AM

07:25 AM

Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

07:25 AM

07:11 AM

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

07:11 AM

06:25 AM

Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com

06:25 AM

04:50 AM

Will Catalyst Pharmaceuticals Inc. stock split again soon2025 Momentum Check & Daily Stock Momentum Reports - newser.com

04:50 AM

04:45 AM

What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

04:45 AM

01:01 AM

Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesWeekly Loss Report & Consistent Return Investment Signals - newser.com

01:01 AM

Nov 02, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025

Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025

What risks investors should watch in Catalyst Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Nov 02, 2025

Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Key Highlights & High Conviction Investment Ideas - newser.com

Nov 02, 2025

Nov 01, 2025

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Earnings Growth Report & Real-Time Volume Analysis - newser.com

Nov 01, 2025

Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.Gap Down & Reliable Price Breakout Signals - newser.com

Nov 01, 2025

Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025